The CDSCO said advertisements — including surrogate promotions — across print, electronic, digital or social media platforms ...

The CDSCO advisory bars direct and indirect promotion of GLP-1 weight-loss drugs, including influencer campaigns and awareness content that create brand recall among consumers ...

India’s Central Drugs Standard Control Organization warns pharma companies against promoting GLP-1 receptor agonists directly to consumers.

This prohibition shall extend to any form of direct or indirect promotional activity in print, electronic, digital, social media, or any other public platform that is intended, directly or indirectly, ...

The Drugs Controller General of India (DCGI) has issued strict warning against any surrogate advertisements, including awareness campaigns, for presc ...

CDSCO warned that any form of advertisement -- direct or indirect -- promoting such medicines to the general public could ...

This report was published from a syndicated wire feed. Apart from the headline, the EdexLive Desk has not edited the copy.

CDSCO issues advisory against misleading promotion of obesity drugs, emphasizing compliance with regulations and importance of lifestyle changes.

CDSCO issues advisory against promotional activities for anti-obesity, metabolic disorder drugs: Our Bureau, New Delhi Thursday, March 12, 2026, 12:45 Hrs [IST] The Central Drugs ...

Report Weekly Horoscope March 8-14: Aries, Taurus to Virgo– Your cosmic forecast and message from Angels Weekly Horoscope March 1-7: Aries, Taurus to Virgo– Your cosmic forecast and message from ...

Advisory cautions companies against surrogate advertising of prescription GLP-1 therapies ...